[1]
Shoaei, S., Sali, S., lali, A., Karamipour, M. and Minooeefar, J. 2017. The Sustained Virologic Response and Adverse Effects of Peg Interferon Alfa and Ribavirin in the Treatment of Patients with Chronic Hepatitis C: A Study from Iran. Novelty in Biomedicine. 5, 4 (Oct. 2017), 172–176. DOI:https://doi.org/10.22037/nbm.v5i4.17355.